CHRS Coherus BioSciences, Inc. Stock Quote

CHRS [NASD]

Index	-	P/E	10.60	EPS (ttm)	2.02	Insider Own	0.40%	Shs Outstand	71.65M	Perf Week	16.76%
Market Cap	1.51B	Forward P/E	20.24	EPS next Y	1.06	Insider Trans	-48.83%	Shs Float	64.13M	Perf Month	23.29%
Income	161.80M	PEG	4.82	EPS next Q	0.23	Inst Own	-	Short Float	24.16%	Perf Quarter	20.51%
Sales	489.30M	P/S	3.09	EPS this Y	138.10%	Inst Trans	0.77%	Short Ratio	16.75	Perf Half Y	15.31%
Book/sh	3.57	P/B	5.99	EPS next Y	-38.55%	ROA	26.60%	Target Price	29.90	Perf Year	13.23%
Cash/sh	7.12	P/C	3.00	EPS next 5Y	2.20%	ROE	88.40%	52W Range	10.86 - 23.03	Perf YTD	23.07%
Dividend	-	P/FCF	11.46	EPS past 5Y	16.20%	ROI	37.00%	52W High	-7.12%	Beta	1.37
Dividend %	-	Quick Ratio	5.20	Sales past 5Y	62.80%	Gross Margin	93.10%	52W Low	96.93%	ATR	0.91
Employees	306	Current Ratio	5.40	Sales Q/Q	1.70%	Oper. Margin	37.80%	RSI (14)	75.05	Volatility	7.22% 4.75%
Optionable	Yes	Debt/Eq	1.58	EPS Q/Q	-44.50%	Profit Margin	33.10%	Rel Volume	5.81	Prev Close	20.43
Shortable	Yes	LT Debt/Eq	1.58	Earnings	Nov 05 AMC	Payout	0.00%	Avg Volume	925.16K	Price	21.39
Recom	1.90	SMA20	19.98%	SMA50	19.15%	SMA200	19.69%	Volume	5,374,783	Change	4.70%

Jul-16-20

Initiated

BofA Securities

Neutral

$20

Apr-17-20

Initiated

SunTrust

Buy

$26

Aug-13-19

Initiated

Mizuho

Buy

Aug-02-19

Reiterated

Maxim Group

Buy

$25 → $27

Aug-02-19

Reiterated

H.C. Wainwright

Buy

$28 → $29

Jun-11-19

Initiated

Barclays

Overweight

$30

May-07-19

Initiated

H.C. Wainwright

Buy

$28

Aug-28-18

Initiated

H.C. Wainwright

Buy

$28

Mar-09-18

Reiterated

Maxim Group

Buy

$20 → $15

Aug-08-17

Reiterated

JP Morgan

Overweight

$32 → $25

Jun-13-17

Reiterated

Maxim Group

Buy

$44 → $40

May-05-17

Initiated

BMO Capital Markets

Outperform

$54

Oct-19-16

Initiated

Robert W. Baird

Outperform

$40

Sep-07-16

Initiated

Maxim Group

Buy

$43

Jul-27-16

Initiated

Citigroup

Buy

$36

Jan-20-16

Initiated

Credit Suisse

Outperform

Jan-22-21 04:01PM	Coherus BioSciences Announces New Employment Inducement Grants GlobeNewswire
Jan-07-21 04:01PM	Coherus BioSciences Appoints Alan Mendelson and Mark Stolper to Board of Directors GlobeNewswire
Jan-05-21 04:01PM	Coherus BioSciences Management to Present at the 39th Annual J.P. Morgan Healthcare Conference GlobeNewswire
Dec-21-20 04:02PM	Coherus BioSciences Announces New Employment Inducement Grants GlobeNewswire
09:54AM	A Look Into Healthcare Sector Value Stocks Benzinga
Nov-20-20 04:01PM	Coherus BioSciences Announces New Employment Inducement Grants GlobeNewswire
Nov-09-20 09:30AM	5 Value Stocks To Watch In The Healthcare Sector Benzinga +6.65%
Nov-07-20 08:22AM	Earnings Miss: Coherus BioSciences, Inc. Missed EPS By 14% And Analysts Are Revising Their Forecasts Simply Wall St.
Nov-06-20 03:30PM	Coherus BioSciences Inc (CHRS) Q3 2020 Earnings Call Transcript Motley Fool -8.75%
Nov-05-20 05:35PM	Coherus BioSciences (CHRS) Lags Q3 Earnings and Revenue Estimates Zacks
04:02PM	Coherus BioSciences Reports Third Quarter 2020 Financial Results GlobeNewswire
02:45PM	Coherus BioSciences, Inc. to Host Earnings Call ACCESSWIRE
Oct-29-20 12:40PM	What's in Store for Perrigo (PRGO) This Earnings Season? Zacks
12:34PM	Coherus BioSciences (CHRS) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release Zacks
Oct-26-20 12:10PM	Why Coherus BioSciences (CHRS) is Poised to Beat Earnings Estimates Again Zacks
12:00PM	Coherus BioSciences (CHRS) Moves to Buy: Rationale Behind the Upgrade Zacks
11:40AM	CHRS or ILMN: Which Is the Better Value Stock Right Now? Zacks
09:51AM	Overview Of Value Stocks In The Healthcare Sector Benzinga
Oct-22-20 04:15PM	Coherus BioSciences to Report Third Quarter Financial Results on November 5th GlobeNewswire
Oct-16-20 09:30AM	Coherus BioSciences Announces New Employment Inducement Grants GlobeNewswire
Oct-05-20 09:44AM	5 Value Stocks To Watch In The Healthcare Sector Benzinga
Sep-28-20 05:23PM	Hedge Funds Are Selling Coherus Biosciences Inc (CHRS) Insider Monkey
Sep-18-20 11:02AM	Coherus BioSciences Announces New Employment Inducement Grants GlobeNewswire
Sep-13-20 10:10AM	Our View On Coherus BioSciences' (NASDAQ:CHRS) CEO Pay Simply Wall St.
Aug-21-20 09:30AM	Coherus BioSciences Announces New Employment Inducement Grants GlobeNewswire
Aug-11-20 03:45PM	Coherus BioSciences Keeps Proving Wall Street Wrong Motley Fool
Aug-06-20 08:10PM	Coherus BioSciences (CHRS) Q2 Earnings and Revenues Top Estimates Zacks
04:02PM	Coherus BioSciences Reports Second Quarter 2020 Financial Results GlobeNewswire
Aug-03-20 04:48PM	Coherus BioSciences Appoints Kimberly Tzoumakas, J.D. to Board of Directors GlobeNewswire
Jul-30-20 12:33PM	Earnings Preview: Coherus BioSciences (CHRS) Q2 Earnings Expected to Decline Zacks
Jul-17-20 09:30AM	Coherus BioSciences Announces New Employment Inducement Grants GlobeNewswire
Jul-16-20 09:30AM	Coherus BioSciences to Report Second Quarter Financial Results on August 6th GlobeNewswire
Jul-14-20 03:49PM	Here's Why Coherus BioSciences (NASDAQ:CHRS) Can Manage Its Debt Responsibly Simply Wall St.
Jul-09-20 08:56PM	Did Hedge Funds Make The Right Call On Coherus Biosciences Inc (CHRS) ? Insider Monkey
Jun-19-20 09:30AM	Coherus BioSciences Announces New Employment Inducement Grants GlobeNewswire
Jun-15-20 04:05PM	Edited Transcript of CHRS earnings conference call or presentation 7-May-20 8:30pm GMT Thomson Reuters StreetEvents
Jun-12-20 08:31AM	2 Top Small-Cap Stocks to Buy Right Now Motley Fool
Jun-03-20 03:35AM	Hedge Funds Arent Done Buying Coherus Biosciences Inc (CHRS) Insider Monkey
May-26-20 06:16PM	Essent Group Set to Join S&P MidCap 400; Coherus BioSciences, Patterson-UTI Energy to Join S&P SmallCap 600 PR Newswire
12:53PM	Is Coherus BioSciences a Buy? Motley Fool
May-21-20 12:47PM	3 Stocks Trading at Attractive Valuations GuruFocus.com -5.74%
May-13-20 07:08PM	Coherus Is a Top Pick for COVID-19 Environment, Says Top Analyst TipRanks
May-10-20 10:47PM	Were Hedge Funds Right About Coherus Biosciences Inc (CHRS)? Insider Monkey
08:59AM	Earnings Update: Coherus BioSciences, Inc. (NASDAQ:CHRS) Just Reported Its First-Quarter Results And Analysts Are Updating Their Forecasts Simply Wall St.
May-08-20 05:30PM	Coherus BioSciences Inc (CHRS) Q1 2020 Earnings Call Transcript Motley Fool
01:05PM	Those Who Purchased Coherus BioSciences (NASDAQ:CHRS) Shares Five Years Ago Have A 31% Loss To Show For It Simply Wall St.
May-07-20 04:08PM	Coherus BioSciences Reports First Quarter 2020 Financial Results GlobeNewswire
May-04-20 09:30AM	Coherus BioSciences Management to Present at BofA Securities 2020 Health Care Conference GlobeNewswire
Apr-30-20 12:34PM	Coherus BioSciences (CHRS) Earnings Expected to Grow: Should You Buy? Zacks
Apr-22-20 09:30AM	Coherus BioSciences to Report First Quarter Financial Results on May 7th GlobeNewswire
Apr-21-20 05:39PM	Coherus Biosciences Shows Rising Relative Price Performance; Still Working On Building Base Investor's Business Daily
Apr-16-20 07:27AM	Check These 7 Top-Ranked Stocks With Solid Net Profit Margins Zacks
Apr-15-20 12:05AM	Coherus BioSciences Prices $200.0 Million Convertible Senior Subordinated Notes Offering GlobeNewswire
Apr-14-20 07:52AM	Coherus BioSciences Announces Proposed Convertible Senior Subordinated Notes Offering GlobeNewswire -6.47%
Apr-13-20 09:23AM	Coherus BioSciences Provides First Quarter 2020 Financial Update and Fiscal Year 2020 COVID-19 Impact Insights GlobeNewswire -5.15%
Apr-08-20 10:49AM	The Zacks Analyst Blog Highlights: AbbVie, Coherus BioSciences, Bluerock Residential Growth REIT, Huntington Ingalls Industries and Installed Building Products Zacks
Apr-07-20 06:59AM	Signs of Coronavirus Slowdown Pep Up Wall Street: 5 Winners Zacks
Mar-26-20 08:34AM	Is Coherus BioSciences (CHRS) Stock a Solid Choice Right Now? Zacks +5.33%
Mar-20-20 09:30AM	Coherus BioSciences Announces New Employment Inducement Grants GlobeNewswire +7.62%
Mar-14-20 02:43AM	Edited Transcript of CHRS earnings conference call or presentation 27-Feb-20 9:30pm GMT Thomson Reuters StreetEvents
Mar-09-20 05:01AM	Zacks.com featured highlights include: LGI Homes, Coherus Biosciences, QIAGEN, Regeneron Pharmaceuticals and Century Communities Zacks -8.14%
Mar-05-20 04:09PM	Coherus BioSciences Management to Present at Barclays Global Healthcare Conference 2020 GlobeNewswire
07:00AM	United States Manufactured UDENYCA® (pegfilgrastim-cbqv) Well Positioned to Meet Market Demand GlobeNewswire
Feb-29-20 08:54AM	Coherus BioSciences, Inc. Just Missed EPS By 10%: Here's What Analysts Think Will Happen Next Simply Wall St.
Feb-27-20 04:01PM	Coherus BioSciences Reports Fourth Quarter and Full Year 2019 Financial Results GlobeNewswire -5.84%
Feb-26-20 09:30AM	Coherus BioSciences Management to Present at the 40th Annual Cowen Healthcare Conference GlobeNewswire
Feb-24-20 09:43AM	Coherus (CHRS) to Report Q4 Earnings: What's in the Cards? Zacks
Feb-20-20 11:19AM	Coherus BioSciences Announces New Employment Inducement Grants GlobeNewswire
Feb-11-20 11:30AM	Has Coherus BioSciences (CHRS) Outpaced Other Medical Stocks This Year? Zacks
Feb-07-20 12:00PM	Coherus BioSciences (CHRS) Upgraded to Strong Buy: Here's Why Zacks +5.92%
Feb-06-20 09:34AM	Coherus BioSciences to Report Fourth Quarter and Full Year Financial Results on February 27th GlobeNewswire
Jan-23-20 11:30AM	Has Coherus BioSciences (CHRS) Outpaced Other Medical Stocks This Year? Zacks
Jan-17-20 08:16AM	Arena's (ARNA) Heart Failure Candidate Gets Fast Track Status Zacks
Jan-13-20 08:30AM	Coherus Acquires Commercial Rights for Avastin® Biosimilar in the United States GlobeNewswire
Jan-08-20 08:53AM	Amarin Posts '19 Preliminary Results, Gives 2020 Expense View Zacks
Jan-07-20 11:30AM	Is Coherus BioSciences (CHRS) Stock Outpacing Its Medical Peers This Year? Zacks
09:59AM	Protagonist (PTGX) Starts Study on PTG-300 for Blood Disorder Zacks
Jan-03-20 09:55AM	Pulmatrix Surges on License Agreement With Johnson & Johnson Zacks
09:30AM	Coherus BioSciences Management to Present at the 38th Annual J.P. Morgan Healthcare Conference GlobeNewswire
09:01AM	Arena (ARNA) Expands Strategic Deal With Beacon Discovery Zacks
Dec-30-19 09:44AM	Flexion's (FLXN) Stock Up on FDA Approval for Zilretta sNDA Zacks
Dec-19-19 11:30AM	Has Coherus BioSciences (CHRS) Outpaced Other Medical Stocks This Year? Zacks
Dec-16-19 09:34AM	5 Biotech Stocks Set for Continued Rally in 2020 Zacks
Dec-07-19 12:25PM	Is Coherus Biosciences Inc (CHRS) A Good Stock To Buy ? Insider Monkey
Dec-03-19 08:51AM	Top Ranked Momentum Stocks to Buy for December 3rd Zacks -5.26%
Nov-26-19 11:27AM	Top Ranked Momentum Stocks to Buy for November 26th Zacks -7.77%
Nov-19-19 09:36AM	Alkermes to Acquire Rodin Therapeutics, Boost CNS Pipeline Zacks
Nov-15-19 11:17PM	Edited Transcript of CHRS earnings conference call or presentation 6-Nov-19 9:30pm GMT Thomson Reuters StreetEvents
10:08AM	Breakout Stocks & Technical Analysis Investor's Business Daily
Nov-12-19 09:30AM	Coherus BioSciences Management to Present at Two Upcoming Investor Healthcare Conferences GlobeNewswire
08:18AM	The Zacks Analyst Blog Highlights: Coherus, Incyte, ACADIA and Celgene Zacks
Nov-11-19 09:28AM	4 Biotech Stocks That Could Keep Beating Wall Street Zacks
Nov-08-19 09:30AM	Coherus BioSciences Announces New Employment Inducement Grants GlobeNewswire
Nov-06-19 06:15PM	Coherus BioSciences (CHRS) Q3 Earnings and Revenues Surpass Estimates Zacks
04:01PM	Coherus BioSciences Reports Corporate Highlights and Third Quarter 2019 Financial Results GlobeNewswire
04:01PM	Coherus Acquires Commercial Rights for Leading Lucentis Biosimilar in the United States GlobeNewswire
Oct-29-19 03:16PM	Investors Can Find Strong Stocks with our First Profit Screen Zacks +5.23%
Oct-28-19 11:18AM	3 Perfect 10 Biotech Stocks to Buy Amid Volatile Market Environment TipRanks
Oct-26-19 01:22PM	Hedge Funds Have Never Been More Bullish On Coherus Biosciences Inc (CHRS) Insider Monkey
Oct-21-19 07:44AM	Are Insiders Selling Coherus BioSciences, Inc. (NASDAQ:CHRS) Stock? Simply Wall St.

Coherus BioSciences, Inc., a commercial-stage biotherapeutics company, focuses on the biosimilar market worldwide. It markets UDENYCA, a long-acting granulocyte stimulating colony factor, which stimulates production of granulocytes in order to promote the body's ability to fight infections. The company sells UDENYCA in the United States. Its product candidates include CHS-1420, an adalimumab (Humira) biosimilar candidate and CHS-0214, an etanercept (Enbrel) biosimilar candidate, which have completed Phase III clinical study for treating psoriasis and rheumatoid arthritis. The company is also developing ranibizumab (Lucentis), an ophthalmology biosimilar candidate; CHS-2020, an aflibercept (Eylea) biosimilar candidate; and CHS-131, a small-molecule drug candidate for non-alcoholic steatohepatitis and other metabolic conditions, as well as bevacizumab (Avastin), an oncology biosimilar candidate. Coherus BioSciences, Inc. has license agreements with Bioeq AG; Innovent Biologics (Suzhou) Co., Ltd.; Daiichi Sankyo Company, Limited; and Selexis SA. The company was formerly known as BioGenerics, Inc. and changed its name to Coherus BioSciences, Inc. in April 2012. Coherus BioSciences, Inc. was founded in 2010 and is headquartered in Redwood City, California.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Viret Jean-Frederic	Chief Financial Officer	Jan 25	Option Exercise	10.05	40,000	402,000	107,439	Jan 27 04:15 PM
Viret Jean-Frederic	Chief Financial Officer	Jan 25	Sale	19.95	46,144	920,736	61,295	Jan 27 04:15 PM
Anicetti Vincent R	Chief Operating Officer	Jan 19	Option Exercise	2.50	2,500	6,251	62,239	Jan 21 04:22 PM
Anicetti Vincent R	Chief Operating Officer	Jan 19	Sale	17.94	2,500	44,852	59,739	Jan 21 04:22 PM
Anicetti Vincent R	Chief Operating Officer	Dec 17	Option Exercise	2.50	2,500	6,251	35,069	Dec 21 04:10 PM
Anicetti Vincent R	Chief Operating Officer	Dec 17	Sale	17.51	2,500	43,780	32,569	Dec 21 04:10 PM
Vexler Vladimir	Chief Scientific Officer	Dec 10	Option Exercise	2.08	17,626	36,729	54,299	Dec 11 04:39 PM
Vexler Vladimir	Chief Scientific Officer	Dec 10	Sale	18.05	17,626	318,066	36,673	Dec 11 04:39 PM
Vexler Vladimir	Chief Scientific Officer	Dec 09	Option Exercise	2.08	30,000	62,514	86,185	Dec 11 04:39 PM
Vexler Vladimir	Chief Scientific Officer	Dec 09	Sale	18.24	49,512	903,084	36,673	Dec 11 04:39 PM
Anicetti Vincent R	Chief Operating Officer	Dec 07	Option Exercise	12.59	8,791	110,656	41,360	Dec 09 05:53 PM
Anicetti Vincent R	Chief Operating Officer	Dec 07	Sale	18.42	8,791	161,896	32,569	Dec 09 05:53 PM
Anicetti Vincent R	Chief Operating Officer	Dec 04	Option Exercise	15.37	49,000	753,079	81,569	Dec 07 04:51 PM
Anicetti Vincent R	Chief Operating Officer	Dec 04	Sale	18.85	49,000	923,694	32,569	Dec 07 04:51 PM
Anicetti Vincent R	Chief Operating Officer	Dec 03	Option Exercise	17.32	49,756	861,602	82,325	Dec 07 04:51 PM
Anicetti Vincent R	Chief Operating Officer	Dec 03	Sale	18.67	49,756	929,079	32,569	Dec 07 04:51 PM
Anicetti Vincent R	Chief Operating Officer	Nov 18	Option Exercise	12.70	4,283	54,394	36,852	Nov 19 04:16 PM
Anicetti Vincent R	Chief Operating Officer	Nov 18	Sale	18.00	4,283	77,094	32,569	Nov 19 04:16 PM
Viret Jean-Frederic	Chief Financial Officer	Nov 17	Option Exercise	13.50	1,500	20,250	40,269	Nov 19 04:16 PM
Anicetti Vincent R	Chief Operating Officer	Nov 17	Option Exercise	2.50	2,500	6,251	51,056	Nov 19 04:16 PM
Viret Jean-Frederic	Chief Financial Officer	Nov 17	Sale	17.49	1,995	34,896	38,769	Nov 19 04:16 PM
Anicetti Vincent R	Chief Operating Officer	Nov 17	Sale	17.66	18,487	326,416	32,569	Nov 19 04:16 PM
Anicetti Vincent R	Chief Operating Officer	Oct 19	Option Exercise	4.77	3,217	15,357	51,773	Oct 21 04:04 PM
Anicetti Vincent R	Chief Operating Officer	Oct 19	Sale	17.89	3,217	57,556	48,556	Oct 21 04:04 PM
Viret Jean-Frederic	Chief Financial Officer	Oct 14	Sale	19.00	6,144	116,736	40,423	Oct 16 04:19 PM
Anicetti Vincent R	Chief Operating Officer	Sep 17	Option Exercise	7.60	5,000	38,001	53,556	Sep 21 05:06 PM
Anicetti Vincent R	Chief Operating Officer	Sep 17	Sale	18.84	5,000	94,216	48,556	Sep 21 05:06 PM
Anicetti Vincent R	Chief Operating Officer	Aug 17	Option Exercise	7.60	5,000	38,001	53,556	Aug 19 04:23 PM
Anicetti Vincent R	Chief Operating Officer	Aug 17	Sale	19.37	5,000	96,851	48,556	Aug 19 04:23 PM
Anicetti Vincent R	Chief Operating Officer	Jul 17	Option Exercise	11.00	15,000	165,001	63,556	Jul 21 05:04 PM
Anicetti Vincent R	Chief Operating Officer	Jul 17	Sale	18.25	15,000	273,687	48,556	Jul 21 05:04 PM
Lanfear Dennis M	President & CEO	Jul 01	Option Exercise	0.01	29,994	249	193,258	Jul 06 05:58 PM
Szela Mary T	Director	Jun 22	Option Exercise	8.84	54,997	485,900	54,997	Jun 24 04:55 PM
Szela Mary T	Director	Jun 22	Sale	17.58	54,997	966,759	0	Jun 24 04:55 PM
Anicetti Vincent R	Chief Operating Officer	Jun 17	Option Exercise	2.50	2,500	6,251	51,056	Jun 19 04:35 PM
Anicetti Vincent R	Chief Operating Officer	Jun 17	Sale	17.22	2,500	43,050	48,556	Jun 19 04:35 PM
Wahlstrom Mats	Director	Jun 17	Sale	17.15	200,000	3,430,020	0	Jun 19 04:33 PM
Viret Jean-Frederic	Chief Financial Officer	May 20	Sale	17.66	1,278	22,569	46,567	May 22 04:30 PM
Anicetti Vincent R	Chief Operating Officer	May 18	Option Exercise	2.50	2,500	6,251	51,056	May 20 05:01 PM
Anicetti Vincent R	Chief Operating Officer	May 18	Sale	17.17	3,093	53,107	48,556	May 20 05:01 PM
Anicetti Vincent R	Chief Operating Officer	Apr 20	Sale	17.00	5,150	87,550	47,846	Apr 21 04:24 PM
Anicetti Vincent R	Chief Operating Officer	Apr 17	Option Exercise	2.50	5,000	12,503	57,996	Apr 21 04:24 PM
Anicetti Vincent R	Chief Operating Officer	Apr 17	Sale	15.57	5,000	77,850	52,996	Apr 21 04:24 PM
Wahlstrom Mats	Director	Mar 03	Sale	20.12	118,066	2,375,409	200,000	Mar 05 04:31 PM
Viret Jean-Frederic	Chief Financial Officer	Feb 19	Option Exercise	10.05	3,159	31,748	50,000	Feb 21 06:16 PM
Viret Jean-Frederic	Chief Financial Officer	Feb 19	Sale	22.33	3,159	70,552	46,841	Feb 21 06:16 PM
Anicetti Vincent R	Chief Operating Officer	Feb 18	Option Exercise	7.60	5,000	38,001	60,496	Feb 20 04:07 PM
Anicetti Vincent R	Chief Operating Officer	Feb 18	Sale	21.64	10,000	216,390	52,996	Feb 20 04:07 PM

open in yahoo | open in reuters | open in google

Upgrade your FINVIZ experience